Schrödinger Inc.

23.94
-2.07 (-7.96%)
At close: Feb 20, 2025, 3:59 PM
24.20
1.09%
After-hours: Feb 20, 2025, 06:52 PM EST
undefined%
Bid 24.1
Market Cap 1.74B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.45
PE Ratio (ttm) -9.77
Forward PE n/a
Analyst Buy
Ask 24.45
Volume 1,297,894
Avg. Volume (20D) 820,035
Open 25.81
Previous Close 26.01
Day's Range 23.50 - 25.93
52-Week Range 16.67 - 33.63
Beta undefined

About SDGR

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on...

Sector Healthcare
IPO Date Feb 6, 2020
Employees 900
Stock Exchange NASDAQ
Ticker Symbol SDGR
Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $29.5, which is an increase of 23.22% from the latest price.

Buy 66.67%
Hold 33.33%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Schrödinger Inc. is scheduled to release its earnings on Feb 26, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+14.11%
Schrodinger shares are trading higher following me... Unlock content with Pro Subscription
3 months ago
+13.87%
Schrodinger shares are trading higher after the company raised its FY24 software revenue growth guidance. Additioanlly, the company announced a research collaboration and license agreement with Novartis to advance multiple development candidates.